全球癌症疫苗市场研究报告 - 产业分析、规模、份额、成长、趋势及预测（2025 年至 2033 年）

全球癌症疫苗市场预计将大幅成长，预计市场规模将从 2024 年的 95.9 亿美元飙升至 2033 年的 249.5 亿美元，预测期内年复合成长率(CAGR) 高达 11.21%。

随着免疫疗法在肿瘤治疗模式中日益凸显，癌症疫苗市场正在快速发展。癌症疫苗旨在刺激免疫系统识别并攻击肿瘤细胞，包括针对子宫颈癌、前列腺癌和黑色素瘤等多种癌症的预防性和治疗性疫苗。包括肽基疫苗、树突细胞疫苗和mRNA疫苗在内的疫苗平台的创新正在提升疫苗的特异性、有效性和安全性。

癌症疫苗与检查点抑制剂和个人化医疗方法的结合正在拓展临床应用。生物标记识别和基因组分析的进步支持患者分层和疫苗定制。监管部门的批准和临床试验的成功正在加速市场成长。此外，癌症发生率和认知度的提高也推动了对新型免疫疗法的需求。

生物技术公司、研究机构和医疗保健提供者之间的合作正在促进创新和商业化。随着免疫肿瘤学的发展，癌症疫苗市场有望显着成长，为改善患者预后提供有前景的治疗选择。

我们的报告经过精心设计，旨在为客户提供关于各个行业和市场的全面且切实可行的洞察。每份报告都包含几个关键部分，以确保客户全面了解市场格局：

市场概况：对市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本部分探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准，将市场细分为不同的细分市场。此分析重点在于突出每个细分市场的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本部分深入分析了领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，对特定时期的市场规模和成长趋势进行预测。这包括定量分析和图形表示，以说明未来的市场发展轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前及新兴市场趋势、技术创新和潜在投资领域。本部分提供对未来市场发展和成长前景的洞察。

涵盖的细分市场列表

癌症疫苗市场报告的此部分提供了国家和地区层面的细分详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按疫苗类型

• 预防癌症疫苗
• 治疗性癌症疫苗
• 其他的

依适应症类型

• 摄护腺癌
• 膀胱癌
• 黑色素瘤
• 子宫颈癌
• 其他

依技术类型

• 重组癌症疫苗
• 全细胞癌症疫苗
• 病毒载体和DNA癌症疫苗
• 其他技术
• 报告中介绍的公司列表
• 默克公司、葛兰素史克公司、Dendreon Pharmaceuticals LLC、Dynavax Technologies Corporation、Ferring BV、安进、Moderna Inc.、赛诺菲、阿斯特捷利康、百时美施贵宝。

如果您有任何客製化需求，请联络我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第三章：癌症疫苗－产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 按疫苗类型进行的市场吸引力分析
  • 按适应症类型分析市场吸引力
  • 按技术类型分析市场吸引力
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第五章：全球癌症疫苗市场分析：依疫苗类型

• 依疫苗类型概述
• 依疫苗类型分析历史和预测数据
• 预防癌症疫苗
• 治疗性癌症疫苗
• 其他的

第六章：全球癌症疫苗市场分析：依适应症类型

• 依适应症类型概览
• 依适应症类型分析历史和预测数据
• 摄护腺癌
• 膀胱癌
• 黑色素瘤
• 子宫颈癌
• 其他

第七章：全球癌症疫苗市场分析：依技术类型

• 依技术类型概览
• 按技术类型进行的历史和预测资料分析
• 重组癌症疫苗
• 全细胞癌症疫苗
• 病毒载体和DNA癌症疫苗
• 其他技术

第 8 章：全球癌症疫苗市场分析：按地区

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第九章：癌症疫苗公司的竞争格局

• 癌症疫苗市场竞争
• 伙伴关係/合作/协议
• 併购
• 新产品发布
• 其他发展

第十章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Merck & Co. Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• GSK Plc
• 公司概况
• 公司收入
• 产品
• 最新动态
• Dendreon Pharmaceuticals LLC
• 公司概况
• 公司收入
• 产品
• 最新动态
• Dynavax Technologies Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• Ferring BV
• 公司概况
• 公司收入
• 产品
• 最新动态
• Amgen Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Moderna Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Sanofi
• 公司概况
• 公司收入
• 产品
• 最新动态
• AstraZeneca
• 公司概况
• 公司收入
• 产品
• 最新动态
• Bristol Myers Squibb
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，或者在私人公司的情况下可能不涵盖

Global Cancer Vaccines Market is poised for a significant growth, with market size projected to surge from USD 9.59 Billion in 2024 to USD 24.95 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 11.21% during the forecast period.

The cancer vaccines market is advancing rapidly as immunotherapy gains prominence in oncology treatment paradigms. Cancer vaccines, designed to stimulate the immune system to recognize and attack tumor cells, include prophylactic and therapeutic types targeting various cancers such as cervical, prostate, and melanoma. Innovations in vaccine platforms, including peptide-based, dendritic cell, and mRNA vaccines, are enhancing specificity, efficacy, and safety profiles.

The integration of cancer vaccines with checkpoint inhibitors and personalized medicine approaches is expanding clinical applications. Advances in biomarker identification and genomic profiling support patient stratification and vaccine customization. Regulatory approvals and clinical trial successes are accelerating market growth. Additionally, increasing cancer incidence and awareness are driving demand for novel immunotherapies.

Collaborations among biotech firms, research institutions, and healthcare providers are fostering innovation and commercialization. As immuno-oncology evolves, the cancer vaccines market is positioned for significant growth, offering promising therapeutic options to improve patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Cancer Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Vaccine Type

• Preventive Cancer Vaccines
• Therapeutic Cancer Vaccines
• Others

By Indication Type

• Prostate Cancer
• Bladder Cancer
• Melanoma
• Cervical Cancer
• Other

By Technology Type

• Recombinant Cancer Vaccines
• Whole-cell Cancer Vaccines
• Viral Vector and DNA Cancer Vaccines
• Other Technologies
• List of Companies Profiled in the report
• Merck & Co. Inc., GSK plc, Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, Ferring B.V., Amgen Inc., Moderna Inc., Sanofi, AstraZeneca, Bristol Myers Squibb.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CANCER VACCINES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Vaccine Type
  • 3.7.2 Market Attractiveness Analysis By Indication Type
  • 3.7.3 Market Attractiveness Analysis By Technology Type
  • 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER VACCINES MARKET ANALYSIS BY VACCINE TYPE

• 5.1. Overview By Vaccine Type
• 5.2. Historical and Forecast Data Analysis By Vaccine Type
• 5.3. Preventive Cancer Vaccines Historic and Forecast Sales By Regions
• 5.4. Therapeutic Cancer Vaccines Historic and Forecast Sales By Regions
• 5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL CANCER VACCINES MARKET ANALYSIS BY INDICATION TYPE

• 6.1. Overview By Indication Type
• 6.2. Historical and Forecast Data Analysis By Indication Type
• 6.3. Prostate Cancer Historic and Forecast Sales By Regions
• 6.4. Bladder Cancer Historic and Forecast Sales By Regions
• 6.5. Melanoma Historic and Forecast Sales By Regions
• 6.6. Cervical Cancer Historic and Forecast Sales By Regions
• 6.7. Other Historic and Forecast Sales By Regions

7. GLOBAL CANCER VACCINES MARKET ANALYSIS BY TECHNOLOGY TYPE

• 7.1. Overview By Technology Type
• 7.2. Historical and Forecast Data Analysis By Technology Type
• 7.3. Recombinant Cancer Vaccines Historic and Forecast Sales By Regions
• 7.4. Whole-cell Cancer Vaccines Historic and Forecast Sales By Regions
• 7.5. Viral Vector and DNA Cancer Vaccines Historic and Forecast Sales By Regions
• 7.6. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL CANCER VACCINES MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER VACCINES COMPANIES

• 9.1. Cancer Vaccines Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF CANCER VACCINES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Merck & Co. Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. GSK Plc
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Dendreon Pharmaceuticals LLC
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Dynavax Technologies Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Ferring B.V.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Amgen Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Moderna Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Sanofi
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. AstraZeneca
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Bristol Myers Squibb
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Vaccine Type (USD MN)
• Preventive Cancer Vaccines Market Sales By Geography (USD MN)
• Therapeutic Cancer Vaccines Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Indication Type (USD MN)
• Prostate Cancer Market Sales By Geography (USD MN)
• Bladder Cancer Market Sales By Geography (USD MN)
• Melanoma Market Sales By Geography (USD MN)
• Cervical Cancer Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Analysis By Technology Type (USD MN)
• Recombinant Cancer Vaccines Market Sales By Geography (USD MN)
• Whole-cell Cancer Vaccines Market Sales By Geography (USD MN)
• Viral Vector and DNA Cancer Vaccines Market Sales By Geography (USD MN)
• Other Technologies Market Sales By Geography (USD MN)
• Global Cancer Vaccines Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Cancer Vaccines Report
• Market Research Process
• Market Research Methodology
• Global Cancer Vaccines Market Size, By Regions (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Vaccine Type
• Market Attractiveness Analysis By Indication Type
• Market Attractiveness Analysis By Technology Type
• Market Attractiveness Analysis By Regions
• Value Chain Analysis
• Global Market Analysis By Vaccine Type (USD MN)
• Preventive Cancer Vaccines Market Sales By Geography (USD MN)
• Therapeutic Cancer Vaccines Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Indication Type (USD MN)
• Prostate Cancer Market Sales By Geography (USD MN)
• Bladder Cancer Market Sales By Geography (USD MN)
• Melanoma Market Sales By Geography (USD MN)
• Cervical Cancer Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Analysis By Technology Type (USD MN)
• Recombinant Cancer Vaccines Market Sales By Geography (USD MN)
• Whole-cell Cancer Vaccines Market Sales By Geography (USD MN)
• Viral Vector and DNA Cancer Vaccines Market Sales By Geography (USD MN)
• Other Technologies Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.